Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban and Apixaban for Prevention of EHIT After GSV Ablation
NCT07699796Phase 4Completed
- Sponsor
- Heart, Artery, and Vein Center of Fresno
- Start
- Mar 2018
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban, rivaroxaban in deep vein thrombosis (DVT), sponsored by Heart, Artery, and Vein Center of Fresno. Started Mar 2018; status: completed.
02
Drugs
apixabanrivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT07699796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07699796.